2-phenoxyand 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders

Details for Australian Patent Application No. 2004224807 (hide)

Owner Bayer HealthCare AG

Inventors Sugimoto, Hiromi; Li, Yingfu; Marumo, Makiko; Yoshida, Nagahiro; Tsuno, Naoki; Hashimoto, Kentaro; Bacon, Kevin; Moriwaki, Toshiya; Nunami, Noriko; Urbahns, Klaus; Fukushima, Keiko

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004224807

PCT Pub. Number WO2004/084898

Priority 03006293.9 24.03.03 EP

Filing date 11 March 2004

Wipo publication date 7 October 2004

International Classifications

A61K 031/4965 - Non-condensed pyrazines

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 031/439 - the ring forming part of a bridged ring system, e.g. quinuclidine

C07D 403/06 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 031/497

C07C 311/37 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 031/4015 - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

C07D 243/08 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 207/40 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/34 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 031/405

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/084898 Priority application(s): WO2004/084898

10 December 2009 Assignment before Grant

  Actimis Pharmaceuticals, Inc. The application has been assigned to Axikin Pharmaceuticals, Inc.

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224809-Disposable packaging for the distribution of a liquid preparation pumped by a venturi-effect device

2004224806-Gelled food product with a liquid centre